Civil Society From 17 European Countries File Patent Opposition On Key Hepatitis C Drug 27/03/2017 by Intellectual Property Watch 2 Comments Public health group Médecins Sans Frontières (MSF) announced today that it has joined civil society organisations from 17 countries in Europe in filing a patent challenge at the European Patent Office to Gilead’s patent on sofosbuvir, an important treatment for hepatitis C.
Medicines Patent Pool Sublicenses New Antibiotic Candidate To TB Alliance For Development 24/03/2017 by Intellectual Property Watch 2 Comments TB Alliance and the Medicines Patent Pool announced today a licensing agreement for the development of sutezolid, a new antibiotic drug candidate which may be used to treat tuberculosis.
Will Brexit Block The European Unitary Patent? 23/03/2017 by Intellectual Property Watch 1 Comment European Patent Office President Benoît Battistelli today in Brussels expressed confidence that the first European Union unitary patent could be granted by the end of this year despite continued delays in the ratification process.But doubts remain.
EPO Official Aggressively Promotes Software Patents At CEBIT Fair 22/03/2017 by Intellectual Property Watch 1 Comment At the world‘s biggest computer fair, the CEBIT in Hannover, Germany today, an official of the European Patent Office promoted patents for computer-implemented inventions (CII), also called software patents by critics. CII continues to grow considerably, according to EPO.
A Look At Optimal Patent Regimes For Canada 21/03/2017 by Intellectual Property Watch 2 Comments A new policy brief from the Centre for International Governance Innovation, in Waterloo, Canada argues that Canada should pursue a weaker national patent regime. Acknowledging that Canada already has agreed to certain levels of protection through international treaties and trade agreements, Blit warns that future agreements that strengthen intellectual property protections would not benefit Canada.
Chile: Civil Society, Members Of Congress Urge Issuance Of Compulsory Licences 21/03/2017 by Intellectual Property Watch 1 Comment Representatives of Chilean civil society and Congress this week presented the Chilean health minister with a proposal urging the government to take advantage of international trade law and a newly passed congressional resolution to issue compulsory licences on high-priced drugs for hepatitis C and prostate cancer.
Under Pressure, US Confirms Michelle Lee Is Still USPTO Director 14/03/2017 by Intellectual Property Watch 1 Comment A letter made public only by a United States Freedom of Information Act (FOIA) request confirms that Michelle Lee remains the director of the US Patent and Trademark Office (USPTO), ending a mystery that has been curiously kept secret since President Trump took office over 50 days ago.
Inertia Slows Evolution For Open Scientists 10/03/2017 by Intellectual Property Watch 3 Comments It is still a long way to a new generation of “open scientists”, German open data researcher Christian Heise found out in his just-published PhD thesis. Heise not only investigated drivers and barriers for what he expects to be an evolution from open access to open science by theory and a survey of over 1100 scientists. He tried the concept open science the hard way, opening up the writing of his thesis paper on the net.
EPO Sees Highest Patent Filings Ever; Chinese Applications Still Rising 07/03/2017 by Intellectual Property Watch 2 Comments The European Patent Office published its 2016 annual report today, showing an “unprecedented level of patent filings,” and underlining the growing number of patent applications from China. The top technical fields for applications included medical technology, digital communication, and pharmaceuticals.
First Access To Vaccines Index Published 06/03/2017 by Intellectual Property Watch 3 Comments An “Access to Vaccines Index” was released today in the Netherlands that claims to “reveal the first landscape of vaccine company actions to improve immunisation coverage.”